These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2905869)

  • 1. Cardiovascular risk factors and antihypertensive therapy.
    Weinberger MH
    Am J Med; 1988 Apr; 84(4A):24-9. PubMed ID: 2905869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Goals of antihypertensive therapy.
    McVeigh GE; Flack J; Grimm R
    Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current drug treatment and treatment patterns with antihypertensive drugs.
    Freis ED; Papademetriou V
    Drugs; 1996 Jul; 52(1):1-16. PubMed ID: 8799681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
    Rahn KH
    Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug therapy for hypertension in the elderly.
    Kligman EW; Higbee MD
    J Fam Pract; 1989 Jan; 28(1):81-7. PubMed ID: 2563274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin sensitivity and blood lipids during antihypertensive treatment with special reference to ACE inhibition.
    Pollare T
    J Diabet Complications; 1990; 4(2):75-8. PubMed ID: 1976644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk reduction for stroke and coronary events.
    Peverill RE
    Lancet; 2002 Apr; 359(9313):1249; author reply 1250-1. PubMed ID: 11955568
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiotensin converting enzyme inhibition in clinical practice. A re-examination of stepped-care: a retrospective and a prospective.
    Zanchetti A
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S126-31. PubMed ID: 2580166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Special considerations in the therapy of diabetic hypertension.
    Guzmán CB; Sowers JR
    Prog Cardiovasc Dis; 1999; 41(6):461-70. PubMed ID: 10445870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project.
    Niskanen L; Hedner T; Hansson L; Lanke J; Niklason A;
    Diabetes Care; 2001 Dec; 24(12):2091-6. PubMed ID: 11723089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension in the elderly.
    Byyny RL
    Am J Med; 1986 Dec; 81(6):1055-8. PubMed ID: 3541591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating essential hypertension. The first choice is usually a thiazide diuretic.
    Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Are the newer antihypertensive agents better and more effective than diuretics?].
    Landmark K
    Tidsskr Nor Laegeforen; 2001 Feb; 121(6):701-5. PubMed ID: 11293353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
    Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
    JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative efficacy of, and some adverse reactions to, different antihypertensive regimens.
    Moser M
    Am J Cardiol; 1989 Jan; 63(4):2B-7B. PubMed ID: 2563187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factors to be considered at the beginning of antihypertensive therapy in diabetes mellitus].
    Jermendy G
    Orv Hetil; 2004 May; 145(18):949-56. PubMed ID: 15188641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Revival of antihypertensive therapy: use of thiazide diuretics].
    Nagy V
    Orv Hetil; 2004 Mar; 145(13):669-76. PubMed ID: 15125317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diuretics for cardiovascular prevention in the elderly.
    Hanon O; Seux ML; Lenoir H; Rigaud AS; Girerd X; Forette F
    J Hum Hypertens; 2004 Dec; 18 Suppl 2():S15-22. PubMed ID: 15592568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.